Alternative anticonvulsant drugs for dogs with seizure disorders

Veterinary Medicine

Volumn 99, Issue 9, 2004, Pages 786-793

  Dewey, Curtis W ^a   Barone, Georgina ^a   Smith, Kerry ^a   Kortz, Gregg D ^b  

^a Long Island Veterinary Specialists ^*  (United States)

^b CA Vet Neurol Neurosurg S   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BROMIDE; CLORAZEPATE; DIAZEPAM; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; NORDAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; TIAGABINE; TOPIRAMATE; ZONISAMIDE;

APLASTIC ANEMIA; ATAXIA; BLOOD DYSCRASIA; BULIMIA; DOG; DRUG EFFICACY; DRUG SAFETY; GAIT DISORDER; HUMAN; KERATOCONJUNCTIVITIS SICCA; LEUKOPENIA; LIVER DISEASE; LIVER DYSFUNCTION; LIVER TOXICITY; NONHUMAN; POLYDIPSIA; POLYURIA; REVIEW; SALIVATION; SEDATION; SEIZURE; THROMBOCYTOPENIA; TREMOR; VISUAL IMPAIRMENT; VOMITING; WEIGHT GAIN; WITHDRAWAL SYNDROME;

CANIS FAMILIARIS;

EID: 6444226787     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Thomas, W.B.: Seizures and narcolepsy. A Practical Guide to Canine and Feline Neurology (C.W. Dewey, ed.). Iowa State Press, Ames, 2003; pp 193-212.
2. Boothe, D.M.: Anticonvulsants and other neurologic therapies in small animals. Small Animal Clinical Pharmacology and Therapeutics (D.M. Boothe, ed.). W.B. Saunders, Philadelphia, Pa., 2001; pp 431-456.
3. Podell, M.: Strategies of antiepileptic drug therapy. Proc. ACVIM, ACVIM, Denver, Colo., 2001; pp 430-432.
4. Forrester, S.D. et al.: Disposition of clorazepate in dogs after single- and multiple-dose oral administration. AJVR 51 (12):2001-2005; 1990.
5. Forrester, S.D. et al.: Effects of a 44-day administration of phenobarbital on disposition of clorazepate in dogs. AJVR 54 (7):1136-1138; 1993.
6. Brown, S.A.; Forrester, S.D.: Serum disposition of oral clorazepate from regular-release and sustained-delivery tablets in dogs. J. Vet. Pharmacol. Ther. 14 (4):426-429; 1991.
7. Scherkl, R. et al.: Clorazepate in dogs: Tolerance to the anticonvulsant effect and signs of physical dependence. Epilepsy Res. 3 (2):144-150; 1989.
8. Podell, M.: Antiepileptic drug therapy. Clin. Tech. Small Anim. Pract. 13 (3):185-192; 1998.
9. Palmer, K.J.; McTavish, D.: Felbamate: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drugs 45 (6):1041-1065; 1993.
10. Sisson, A.: Current experiences with anticonvulsants in dogs and cats. Proc. ACVIM, ACVIM, Lake Buena Vista, Fla., 1997; pp 596-598.
11. A receptors. Ann. Neurol. 35 (2):229-234; 1994.
12. Yang, J.T. et al.: Felbamate metabolism in the rat, rabbit, and dog. Drug Metab. Dispos. 19 (6):1126-1134; 1991.
13. Adusumalli, V.E. et al.: Pharmacokinetics of felbamate in pediatric and adult beagle dogs. Epilepsia 33 (5):955-960; 1992.
14. Yang, J.T. et al.: Felbamate metabolism in pediatric and adult beagle dogs. Drug Metab. Dispos. 20 (1):84-88; 1992.
15. McGee, J.H. et al.: Acute, subchronic, and chronic toxicity studies with felbamate, 2-phenyl-1,3-propanediol dicarbamate. Toxicol. Sci. 45 (2):225-232; 1998.
16. Dayrell-Hart, B. et al.: Efficacy and safety of felbamate as an anticonvulsant in dogs with refractory seizures (abst). J. Vet. Intern. Med. 10 (3):174; 1996.
17. Johannessen, S.I. et al.: Therapeutic drug monitoring of the newer antiepileptic drugs. Ther. Drug Monit. 25 (3):347-363; 2003.
18. Bazil, C.W.: New antiepileptic drugs. Neurologist 8 (2):71-81; 2002.
19. Ruehlmann, D. et al.: Treatment of partial seizures and seizure-like activity with felbamate in six dogs. J. Small Anim. Pract. 42 (8):403-408; 2001.
20. Radulovic, L.L. et al.: Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab. Dispos. 23 (4):441-448; 1995.
21. Vollmer, K.O. et al.: Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Drug Res. 36 (5):830-839; 1986.
22. Leppik, I.E.: The place of levetiracetam in the treatment of epilepsy. Epilepsia 42 (suppl. 4):44-45; 2001.
23. Hovinga, C.A.: Levetiracetam: A novel antiepileptic drug. Pharmacotherapy 21 (11):1375-1388; 2001.
24. Shorvon, S.D.; van Rijckevorsel, K.: A new antiepileptic drug (editorial). J. Neurol. Neurosurg. Psychiatry 72 (4):426-429; 2002.
25. Krakow, K. et al.: Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 56 (12):1772-1774; 2001.
26. Morrell, M.J. et al.: The KEEPER trial: Levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study. Epilepsy Res. 54 (2-3):153-161; 2003.
27. Isoherranen, N. et al.: Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs. Epilepsia 42 (7):825-830; 2001.
28. Steinberg, M.; Faissler, D.: Levetiracetam therapy for long-term idiopathic epileptic dogs (abst.). J. Vet. Intern. Med. 18 (3):410; 2004.
29. Oommen, K.J.; Mathews, S.: Zonisamide: A new antiepileptic drug. Clin. Neuropharmacol. 22 (4):192-200; 1999.
30. Leppik, I.E.: Zonisamide. Epilepsia 40 (suppl. 5):S23-S29; 1999.
31. Mori, A. et al.: The anticonvulsant zonisamide scavenges free radicals. Epilepsy Res. 30 (2):153-158; 1998.
32. Faught, E. et al.: Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57 (10):1774-1779; 2001.
33. Leppik, I.E. et al.: Efficacy and safety of Zonisamide: Results of a multicenter study. Epilepsy Res. 14 (2):165-173; 1993.
34. 14C] methyl)-1,2-benzisoxazole (AD-810) in rats, dogs and monkeys and of AD-810 in men. Drug Res. 33 (7):961-968; 1983.
35. Shinoda, M. et al.: The necessity of adjusting the dosage of zonisamide when coadministered with other antiepileptic drugs. Biol. Pharm. Bull. 19 (8):1090-1092; 1996.
36. Dewey, C.W. et al.: Zonisamide therapy for refractory idiopathic epilepsy in dogs. JAAHA 40 (4):285-291; 2004.
37. Walker, R.M. et al.: Chronic toxicity of the anticonvulsant zonisamide in beagle dogs. Fundam. Appl. Toxicol. 11 (2):333-342; 1988.
38. Schicht, S. et al.: Pharmacokinetics of oxcarbazepine in the dog. J. Vet. Pharmacol. Ther. 19 (1):27-31; 1996.
39. Reddy, D.S.: Tiagabine: A potent antiepileptic drug with selective GABA uptake inhibitory effect. Indian J. Pharmacol. 30:141-151; 1998.
40. Streeter, A.J. et al.: Pharmacokinetics and bioavailability of topiramate in the beagle dog. Drug Metab. Dispos. 23 (1):90-93; 1995.